Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parathyroid hormone (teriparatide) for adynamic bone disease in chronic kidney disease
2018-003888-56Phase 4Active
- Sponsor
- Department of Nephrology, Herlev & Gentofte Hospital, Herlev Hospital
- Start
- Jun 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of teriparatide in adynamic bone disease (ABD) and chronic kidney disease-mineral and bone disorder (CKD-MBD) (2 arms), sponsored by Department of Nephrology, Herlev & Gentofte Hospital, Herlev Hospital. Started Jun 2020; status: active.
02
Drugs
teriparatide
03
Conditions
adynamic bone disease (ABD)chronic kidney disease-mineral and bone disorder (CKD-MBD)
Beyond the preview
Go deeper on 2018-003888-56.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003888-56.